Paychex, Inc. Schedules Second Quarter Fiscal 2024 Earnings Conference Call for December 21, 2023
ROCHESTER, N.Y.–(BUSINESS WIRE)–Paychex, Inc. (Nasdaq: PAYX) will release financial results for its fiscal 2024 second quarter ended November 30, 2023.... Read more.
AM Best Affirms Credit Ratings of Assicurazioni Generali S.p.A. and Its Main Rated Subsidiaries
AMSTERDAM–(BUSINESS WIRE)–#insurance—AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit... Read more.
City of Hope Doctors and Scientists Present Innovative Research at Largest Gathering on Breast Cancer Research
Research topics include the use of estrogen therapy in postmenopausal women, City of Hope’s Couples Coping With Cancer Together and genetic testing LOS ANGELES–(BUSINESS... Read more.
Backlight Wins IABM Community Impact Award for its Support of the Howard University Film Organization
BOSTON–(BUSINESS WIRE)–#WeAreBacklight–Global media and entertainment technology company, Backlight, was awarded the International Association... Read more.
UK Hair and Beauty Industry Revenue Projected to Reach £4.6 Billion by 2029 Despite Inflation
Market research data projects steady economic growth for the hair salon and beauty industry, which has shown great resilience even through inflation, where recent... Read more.
bluebird bio Details Plans for the Commercial Launch of LYFGENIA™ Gene Therapy for Patients Ages 12 and Older with Sickle Cell Disease and a History of Vaso-Occlusive Events
Outcomes-based contract offerings available to both commercial payers and Medicaid LYFGENIA will be available through bluebird’s established national network of... Read more.
Ribometrix Demonstrates Rapid Progress for eIF4E Program at San Antonio Breast Cancer Symposium
– New preclinical data show anti-tumor response to Company’s eIF4E inhibitors in ER+ breast cancer – – In vivo proof-of-concept of Ribometrix’s small molecule... Read more.
AM Best Downgrades Credit Ratings of McMillan-Warner Mutual Insurance Company
OLDWICK, N.J.–(BUSINESS WIRE)–AM Best has downgraded the Financial Strength Rating to B- (Fair) from B+ (Good) and the Long-Term Issuer Credit Rating... Read more.
Vertex and CRISPR Therapeutics Announce US FDA Approval of CASGEVY™ (exagamglogene autotemcel) for the Treatment of Sickle Cell Disease
– First-ever approval of a CRISPR-based gene-editing therapy in the U.S. – – Approximately 16,000 patients 12 years of age and older with severe sickle cell... Read more.
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against EHang Holdings Limited (EH)
BENSALEM, Pa.–(BUSINESS WIRE)–Law Offices of Howard G. Smith reminds investors of the upcoming February 2, 2024 deadline to file a lead plaintiff motion... Read more.